Cullinan Therapeutics, Inc. (CGEM) stock
CGEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$9.01−0.27 (-2.86%)
Close on Nov 18, 2026Market cap $579.84MP/E –Yield –
Cullinan Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cullinan Therapeutics's market cap was $730.32M on Nov 11, 2026, against $671.70M a year earlier. Over the last 5 years it ranged from $350.21M to $1.42B, with a median of $603.36M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $730.32M | +19.4% |
| 2025 | Dec 31, 2025 | $611.44M | -13.7% |
| 2024 | Dec 31, 2024 | $708.16M | +62.5% |
| 2023 | Dec 29, 2023 | $435.73M | -9.7% |
| 2022 | Dec 30, 2022 | $482.59M | -28.4% |
| 2021 | Dec 31, 2021 | $673.69M | – |
See a number that looks wrong?